InnoCare Pharma Ltd
HKEX:9969
Wall Street
Price Targets
Price Targets Summary
InnoCare Pharma Ltd
According to Wall Street analysts, the average 1-year price target for InnoCare Pharma Ltd is 7.8 HKD with a low forecast of 7.56 HKD and a high forecast of 8.19 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is InnoCare Pharma Ltd's stock price target?
Price Target
7.8
HKD
According to Wall Street analysts, the average 1-year price target for InnoCare Pharma Ltd is 7.8 HKD with a low forecast of 7.56 HKD and a high forecast of 8.19 HKD.
What is InnoCare Pharma Ltd's Revenue forecast?
Projected CAGR
29%
For the last 1 year the compound annual growth rate for InnoCare Pharma Ltd's revenue is -40%. The projected CAGR for the next 4 years is 29%.